Strativa Pharmaceuticals: News

07/02/2010 FDA Approves Strativa Pharmaceuticals' Zuplenz(R) (ondansetron) Oral Soluble Film
04/16/2010 FDA Approves Oravig(TM) (miconazole) Buccal Tablets for Treatment of Oropharyngeal Candidiasis
02/05/2010 Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
09/14/2009 Strativa Pharmaceuticals’ Development Partner, Bioalliance Pharma, Presents Phase III Study Results Of Miconazole Lauriad® For The Treatment Of Oropharyngeal Candidiasis
08/19/2009 FDA Accepts Drug Application For Miconazole Lauriad® To Treat Oropharyngeal Candidiasis
06/16/2009 Strativa’s Development Partner, Bioalliance Pharma, Submits Loramyc® NDA
06/10/2009 Strativa’s New Drug Application For Ondansetron Orally Dissolving Film Strip Accepted By FDA
04/09/2009 Strativa Pharmaceuticals Provides Product Pipeline Update
04/01/2009 Strativa Pharmaceuticals Acquires Worldwide Rights To Nascobal® (Cyanocobalamin, USP) Nasal Spray From QOL Medical
12/02/2008 Strativa Pharmaceuticals Announces Successful Completion Of Bioequivalence Studies For Ondansetron Thin Film
06/17/2008 Strativa Pharmaceuticals Acquires Commercialization Rights To Thin Film Formulation Of Ondansetron From Monosol Rx
05/29/2008 Strativa Pharmaceuticals Announces Preliminary Results From Onconase® Phase IIIb Clinical Trial
04/21/2008 Strativa Pharmaceuticals Announces Phase III Results For Loramyc® To Treat Oropharyngeal Candidiasis
02/25/2008 Strativa Pharmaceuticals, A Division Of Par Pharmaceutical, Announces The Discontinuation Of The Development Program For Pafuramidine
01/15/2008 Strativa Pharmaceuticals Acquires Commercialization Rights To Onconase® From Alfacell Corporation
12/28/2007 Strativa Provides an Update on Development Status of In-licensed Products